School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong 226001, PR China.
ACS Appl Mater Interfaces. 2021 Nov 17;13(45):53574-53585. doi: 10.1021/acsami.1c15203. Epub 2021 Nov 3.
Chemodynamic therapy (CDT) based on the intracellular Fenton reaction has become increasingly explored in cancer treatment. However, the mildly acidic tumor microenvironment and the limited amount of intracellular hydrogen peroxide (HO) will create issues for CDT to perform a sustained and high-efficiency treatment. Therefore, how to selectively reduce the pH value and augment the amount of HO in tumor tissues has become the key factor for realizing excellent CDT. Besides, the majority of the reported CDT systems have been constructed from iron-based inorganic or metal-organic framework nanomaterials due to the decisive role of metals in CDT, which restricts the development of CDT. In this study, inspired by the host-guest interactions between pillar[6]arene and ferrocene, a ternary pillar[6]arene-based supramolecular nanocatalyst (GO@T-NPs) for CDT is reported for the first time. GO@T-NPs not only exhibited a high-efficiency catalytic ability to convert glucose into hydroxyl radicals (OH) and to reduce the pH value inside cancer cells for significant enhancement of the CDT effect, but they also showed sensitive glutathione-induced camptothecin (CPT) prodrug release capacity for further improving the efficiency of CDT. Hence, GO@NPs possessed excellent ability to synergistically enhance the CDT. Additionally, an antitumor mechanism study showed that the prominent tumor inhibition capacity of GO@T-NPs was derived from trimodal synergistic interactions of CDT, starvation therapy, and chemotherapy. Moreover, GO@T-NPs manifested good biocompatibility and tumor selectivity with few side effects in major organs. This work broadens the range of materials available for CDT and demonstrates new developments in pillar[]arene-based multimodal synergistic treatment systems.
基于细胞内 Fenton 反应的化学动力学疗法(CDT)在癌症治疗中得到了越来越多的探索。然而,肿瘤微环境的轻度酸性和有限的细胞内过氧化氢(HO)含量会给 CDT 的持续高效治疗带来问题。因此,如何选择性地降低肿瘤组织的 pH 值并增加 HO 的含量已成为实现优异 CDT 的关键因素。此外,由于金属在 CDT 中的决定性作用,大多数报道的 CDT 系统都是由基于铁的无机或金属有机骨架纳米材料构建的,这限制了 CDT 的发展。在本研究中,受杯[6]芳烃和二茂铁之间主客体相互作用的启发,首次报道了一种基于三元杯[6]芳烃的超分子纳米催化剂(GO@T-NPs)用于 CDT。GO@T-NPs 不仅表现出高效的催化能力,可将葡萄糖转化为羟基自由基(OH)并降低癌细胞内的 pH 值,从而显著增强 CDT 效应,而且还表现出对谷胱甘肽诱导的喜树碱(CPT)前药释放的敏感能力,进一步提高 CDT 的效率。因此,GO@NPs 具有协同增强 CDT 的优异能力。此外,抗肿瘤机制研究表明,GO@T-NPs 的突出肿瘤抑制能力源于 CDT、饥饿治疗和化学治疗的三模态协同相互作用。此外,GO@T-NPs 在主要器官中表现出良好的生物相容性和肿瘤选择性,副作用较少。这项工作拓宽了用于 CDT 的材料范围,并展示了基于杯[6]芳烃的多模态协同治疗系统的新进展。